Charles River Laboratories CRL EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's EPS (diluted)?
- Charles River Laboratories (CRL) reported EPS (diluted) of -$0.30 in Q1 2026.
- How has Charles River Laboratories's EPS (diluted) changed year-over-year?
- Charles River Laboratories's EPS (diluted) decreased by 160.0% year-over-year, from $0.50 to -$0.30.
- What is the long-term trend for Charles River Laboratories's EPS (diluted)?
- Over 3 years (2021 to 2025), Charles River Laboratories's EPS (diluted) has grown at a -27.5% compound annual growth rate (CAGR), from $7.60 to -$2.90.
- What does EPS (diluted) mean?
- The profit earned per share, assuming all potential shares that could be created are issued.
- How do you interpret EPS (diluted)?
- A higher diluted EPS is preferred; a significant gap between basic and diluted EPS indicates a high level of potential share dilution.
- How does EPS (diluted) compare across companies?
- The primary EPS metric used by analysts for cross-company valuation.